3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
1
Insulin Resistance
1
Inflammation
1
Hyperandrogenism
1
Interventions
Metformin
8
Letrozole
3
Pharmaceutical Preparations
2
semaglutide
1
salicylsalicylic acid
1
mirabegron
1
drospirenone and ethinyl estradiol combination
1
Vitamins
1
Thioctic Acid
1
Progesterone
1
Itraconazole
1
Inositol
1
Hydroquinones
1
Gonadotropin-Releasing Hormone
1
Flutamide
1
Flour
1
Fish Oils
1
Docosahexaenoic Acids
1
Clomiphene
1
Ascorbic Acid
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Polycystic Ovary Syndrome
×
salicylsalicylic acid
×
Clear all
NCT01489319
2017-02-10
ELI-ROAS
Indiana University
Phase 1
Terminated
47 enrolled